Express Pharma

Australia invests AUSD 4 mn for research with India on COVID-19

Apart from new technologies for early detection of COVID-19, the researchers are focusing on the longer-term effects of the virus on the heart and lungs of patients who have recovered

0 383

The Australian government has invested AUSD 4 million for a joint study, along with Indian researchers, into the long-term health effects of COVID-19 and its early detection, the Australian Industry, Science and Technology minister announced.

The Australia-India Strategic Research Fund (AISRF) is financing six new projects, ranging from farming technology to coronavirus detection.

Apart from new technologies for early detection of COVID-19, the researchers are focusing on the longer-term effects of the virus on the heart and lungs of patients who have recovered.

Australian Minister for Industry, Science and Technology Karen Andrews said she was pleased that work in these important areas would be able to continue after the COVID-19 pandemic had caused significant delays this year.

“This latest funding will enable Australian and Indian researchers to contribute to the global response to the COVID-19 pandemic, including in crucial screening and diagnostic testing,” Andrews said.

The Australian recipients of the grants are the University of South Australia, the University of Southern Queensland, the University of Technology Sydney, the Metro North Hospital and Health Service in Brisbane, the University of Adelaide, and the University of Western Australia.

In June 2020, the Australian government had announced that it would commit a further USD 15 million to extend the AISRF for another four years to 2024, bringing Australia”s total contribution to the AISRF fund to nearly AUSD 100 million over 18 years.

The AISRF is Australia’s largest fund dedicated to bilateral science collaboration.

(Edits by EP News Bureau) 

- Advertisement -

Leave A Reply

Your email address will not be published.